PMC:7283670 / 62265-62456 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T363","span":{"begin":52,"end":54},"obj":"Disease"},{"id":"T364","span":{"begin":111,"end":119},"obj":"Disease"},{"id":"T365","span":{"begin":183,"end":191},"obj":"Disease"}],"attributes":[{"id":"A363","pred":"mondo_id","subj":"T363","obj":"http://purl.obolibrary.org/obo/MONDO_0005773"},{"id":"A364","pred":"mondo_id","subj":"T364","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A365","pred":"mondo_id","subj":"T365","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"te the safety and antiviral activity of remdesivir (GS‐5734™) in participants with severe coronavirus disease (COVID‐19) Drug: remdesivir, standard of care United States, Hong Kong/COVID‐19"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T579","span":{"begin":28,"end":36},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"te the safety and antiviral activity of remdesivir (GS‐5734™) in participants with severe coronavirus disease (COVID‐19) Drug: remdesivir, standard of care United States, Hong Kong/COVID‐19"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T155","span":{"begin":18,"end":27},"obj":"Chemical"},{"id":"T156","span":{"begin":40,"end":50},"obj":"Chemical"},{"id":"T157","span":{"begin":52,"end":54},"obj":"Chemical"},{"id":"T158","span":{"begin":128,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A155","pred":"chebi_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A156","pred":"chebi_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A157","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_73516"},{"id":"A158","pred":"chebi_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":"te the safety and antiviral activity of remdesivir (GS‐5734™) in participants with severe coronavirus disease (COVID‐19) Drug: remdesivir, standard of care United States, Hong Kong/COVID‐19"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1888","span":{"begin":65,"end":77},"obj":"Species"},{"id":"2061","span":{"begin":40,"end":50},"obj":"Chemical"},{"id":"2062","span":{"begin":128,"end":138},"obj":"Chemical"},{"id":"2125","span":{"begin":90,"end":109},"obj":"Disease"},{"id":"2126","span":{"begin":111,"end":119},"obj":"Disease"},{"id":"2127","span":{"begin":183,"end":191},"obj":"Disease"}],"attributes":[{"id":"A1888","pred":"tao:has_database_id","subj":"1888","obj":"Tax:9606"},{"id":"A2061","pred":"tao:has_database_id","subj":"2061","obj":"MESH:C000606551"},{"id":"A2062","pred":"tao:has_database_id","subj":"2062","obj":"MESH:C000606551"},{"id":"A2125","pred":"tao:has_database_id","subj":"2125","obj":"MESH:D018352"},{"id":"A2126","pred":"tao:has_database_id","subj":"2126","obj":"MESH:C000657245"},{"id":"A2127","pred":"tao:has_database_id","subj":"2127","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"te the safety and antiviral activity of remdesivir (GS‐5734™) in participants with severe coronavirus disease (COVID‐19) Drug: remdesivir, standard of care United States, Hong Kong/COVID‐19"}